705 related articles for article (PubMed ID: 31070059)
21. Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection.
Aprelikova O; Wood M; Tackett S; Chandramouli GV; Barrett JC
Cancer Res; 2006 Jun; 66(11):5641-7. PubMed ID: 16740701
[TBL] [Abstract][Full Text] [Related]
22. Cancer therapeutic agents targeting hypoxia-inducible factor-1.
Wang R; Zhou S; Li S
Curr Med Chem; 2011; 18(21):3168-89. PubMed ID: 21671859
[TBL] [Abstract][Full Text] [Related]
23. Nuclear FGFR2 negatively regulates hypoxia-induced cell invasion in prostate cancer by interacting with HIF-1 and HIF-2.
Lee JE; Shin SH; Shin HW; Chun YS; Park JW
Sci Rep; 2019 Mar; 9(1):3480. PubMed ID: 30837551
[TBL] [Abstract][Full Text] [Related]
24. Progress on hypoxia-inducible factor-3: Its structure, gene regulation and biological function (Review).
Yang SL; Wu C; Xiong ZF; Fang X
Mol Med Rep; 2015 Aug; 12(2):2411-6. PubMed ID: 25936862
[TBL] [Abstract][Full Text] [Related]
25. [Roles and molecular mechanisms of hypoxia-inducible factors in renal cell carcinoma].
Zou JX; Chen K
Yi Chuan; 2018 May; 40(5):341-356. PubMed ID: 29785943
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2016-2020).
Ban HS; Uto Y; Nakamura H
Expert Opin Ther Pat; 2021 May; 31(5):387-397. PubMed ID: 33455469
[No Abstract] [Full Text] [Related]
27. HIF-2alpha expression in human fetal paraganglia and neuroblastoma: relation to sympathetic differentiation, glucose deficiency, and hypoxia.
Nilsson H; Jögi A; Beckman S; Harris AL; Poellinger L; Påhlman S
Exp Cell Res; 2005 Feb; 303(2):447-56. PubMed ID: 15652356
[TBL] [Abstract][Full Text] [Related]
28. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
29. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
30. VHL and HIF signalling in renal cell carcinogenesis.
Baldewijns MM; van Vlodrop IJ; Vermeulen PB; Soetekouw PM; van Engeland M; de Bruïne AP
J Pathol; 2010 Jun; 221(2):125-38. PubMed ID: 20225241
[TBL] [Abstract][Full Text] [Related]
31. Unraveling the role of hypoxia-inducible factor (HIF)-1α and HIF-2α in the adaption process of human microvascular endothelial cells (HMEC-1) to hypoxia: Redundant HIF-dependent regulation of macrophage migration inhibitory factor.
Hahne M; Schumann P; Mursell M; Strehl C; Hoff P; Buttgereit F; Gaber T
Microvasc Res; 2018 Mar; 116():34-44. PubMed ID: 28993199
[TBL] [Abstract][Full Text] [Related]
32. Current Drugs and their Therapeutic Targets for Hypoxia-inducible Factors in Cancer.
Joshi E; Pandya M; Desai U
Curr Protein Pept Sci; 2023; 24(6):447-464. PubMed ID: 37264663
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.
Semenza GL
Trends Pharmacol Sci; 2012 Apr; 33(4):207-14. PubMed ID: 22398146
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of a redox-silent analogue of tocotrienol on hypoxia adaptation in prostate cancer cells.
Shiozawa N; Sugahara R; Namiki K; Sato C; Ando A; Sato A; Virgona N; Yano T
Anticancer Drugs; 2017 Mar; 28(3):289-297. PubMed ID: 27926612
[TBL] [Abstract][Full Text] [Related]
35. HIF-1alpha and HIF-2alpha are differentially regulated in vivo in neuroblastoma: high HIF-1alpha correlates negatively to advanced clinical stage and tumor vascularization.
Noguera R; Fredlund E; Piqueras M; Pietras A; Beckman S; Navarro S; Påhlman S
Clin Cancer Res; 2009 Dec; 15(23):7130-6. PubMed ID: 19903792
[TBL] [Abstract][Full Text] [Related]
36. HIF-3α Promotes Metastatic Phenotypes in Pancreatic Cancer by Transcriptional Regulation of the RhoC-ROCK1 Signaling Pathway.
Zhou X; Guo X; Chen M; Xie C; Jiang J
Mol Cancer Res; 2018 Jan; 16(1):124-134. PubMed ID: 28928287
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015).
Ban HS; Uto Y; Won M; Nakamura H
Expert Opin Ther Pat; 2016; 26(3):309-22. PubMed ID: 26882240
[TBL] [Abstract][Full Text] [Related]
38. The Krüppel-like zinc finger transcription factor, GLI-similar 1, is regulated by hypoxia-inducible factors via non-canonical mechanisms.
Khalesi E; Nakamura H; Lee KL; Putra AC; Fukazawa T; Kawahara Y; Makino Y; Poellinger L; Yuge L; Tanimoto K
Biochem Biophys Res Commun; 2013 Nov; 441(2):499-506. PubMed ID: 24383088
[TBL] [Abstract][Full Text] [Related]
39. Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition.
Choi H; Chun YS; Kim SW; Kim MS; Park JW
Mol Pharmacol; 2006 Nov; 70(5):1664-71. PubMed ID: 16880289
[TBL] [Abstract][Full Text] [Related]
40. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]